to moderators, page-16

Hi all, new to this thread.

I can confirm that there was a discussionon Sky Business "Your money Your Call" show last night. The discussion was in response to a call in, asking the panels opinion of PRR.

One of the guest brokers (sorry cant recall his name or company) was familiar with PRR. As i recall it, he said that looking at the chart of the share price trend, it did not give a very positive view, BUT the underlying story of the CVAC drug currently undergoing trials ( and he knew the name of the drug and that it related to ovarian cancer) was very interesting. He made a comparative reference to the Dendreon experience.

Hope that helps.
Cheers